Oxford Asset Management’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Oxford Asset Management’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-105,000	Closed	-$21K	–	1983
2019 Q3	$21K	Hold	105,000	–	–	﹤0.01%	1666
2019 Q2	$25K	Hold	105,000	–	–	﹤0.01%	1651
2019 Q1	$19K	Hold	105,000	–	–	﹤0.01%	1614
2018 Q4	$40K	Hold	105,000	–	–	﹤0.01%	1715
2018 Q3	$47K	Hold	105,000	–	–	﹤0.01%	1656
2018 Q2	$40K	Hold	105,000	–	–	﹤0.01%	1661
2018 Q1	$47K	Hold	105,000	–	–	﹤0.01%	1560
2017 Q4	$42K	Buy	+105,000	New	+$40K	﹤0.01%	1571

Other funds holding NRXPW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

VOAM

Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

VAS

VR Advisory Services Camana Bay, Grand Cayman, Cayman Islands $845M AUM 22.79% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Oxford Asset Management's NRXPW Position: Q4 2019 in Review

Oxford Asset Management sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q4 2019, closing a stake of 105,000 shares — an estimated $21K sold.

Oxford Asset Management first reported a position in NRXPW in Q4 2017 and held it in 8 quarters. The position peaked at $47K in Q3 2018. 19 funds tracked by Wall St. Rank hold NRXPW as of Q4 2019.

Oxford Asset Management reported no remaining NRX Pharmaceuticals Warrant position as of Q4 2019 after selling out during the quarter.
Oxford Asset Management sold 105,000 NRX Pharmaceuticals Warrant shares in Q4 2019, an estimated $21K.
Oxford Asset Management first reported a position in NRX Pharmaceuticals Warrant in Q4 2017 and held it in 8 quarters.
Oxford Asset Management's NRX Pharmaceuticals Warrant position peaked at $47K in Q3 2018.
19 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.